Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Crispin

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Internal Medicine Journal|August 22, 2018
Managing hypogammaglobulinaemia secondary to haematological malignancies in Australia and New Zealand: a clinician surveyJonathan Wong, Erica M Wood, Philip Crispin, et al.
Vox Sanguinis|January 28, 2022
A review of electronic medical records and safe transfusion practice for guideline developmentPhilip Crispin, Christine Akers, Kristen Brown, et al.
Internal Medicine Journal|September 18, 2024
Outcomes of a patient support programme for subcutaneous immunoglobulin therapy in patients with primary or secondary immunodeficiencies or chronic inflammatory demyelinating polyneuropathyPhilip Crispin, Robert Henderson, James Yun, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|September 7, 2018
Misinterpretation of blood group and antibody screen leading to serious errors in RhD immunoglobulin administration: A report on first two years of data from Serious Transfusion Incident Reporting programChristine Akers, Helen Savoia, Stefan Kane, et al.
Research and Practice in Thrombosis and Haemostasis|January 29, 2020
The clinical heterogeneity of <i>RUNX1</i> associated familial platelet disorder with predisposition to myeloid malignancy - A case series and review of the literatureCatherine Tang, David J Rabbolini, Marie-Christine Morel-Kopp, et al.
Blood Advances|July 26, 2022
Interventions to reduce infections in patients with hematological malignancies: a systematic review and meta-analysisKhai Li Chai, Jonathan Wong, Robert Weinkove, et al.
BMJ Quality Improvement Reports|August 22, 2017
Improving patient blood management in obstetrics: snapshots of a practice improvement partnershipCindy J Flores, Farah Sethna, Ben Stephens, et al.
Leukemia & Lymphoma|September 13, 2019
Outpatient rituximab, ifosfamide, etoposide (R-IE) in patients older than 60 years with relapsed or refractory diffuse large B-cell lymphoma who are not candidates for stem cell transplantationMaansi Joshi, John Taper, Cecily Forsyth, et al.
Pharmacology Research & Perspectives|October 19, 2019
<i>GSTZ1</i> genotypes correlate with dichloroacetate pharmacokinetics and chronic side effects in multiple myeloma patients in a pilot phase 2 clinical trialDan Dan Tian, Samuel K Bennett, Lucy A Coupland, et al.
Blood Advances|April 9, 2024
Immunoglobulin replacement vs prophylactic antibiotics for hypogammaglobulinemia secondary to hematological malignancyZoe K McQuilten, Robert Weinkove, Le Thi Phuong Thao, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Internal Medicine Journal|August 22, 2018
Managing hypogammaglobulinaemia secondary to haematological malignancies in Australia and New Zealand: a clinician surveyJonathan Wong, Erica M Wood, Philip Crispin, et al.
Vox Sanguinis|January 28, 2022
A review of electronic medical records and safe transfusion practice for guideline developmentPhilip Crispin, Christine Akers, Kristen Brown, et al.
Internal Medicine Journal|September 18, 2024
Outcomes of a patient support programme for subcutaneous immunoglobulin therapy in patients with primary or secondary immunodeficiencies or chronic inflammatory demyelinating polyneuropathyPhilip Crispin, Robert Henderson, James Yun, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|September 7, 2018
Misinterpretation of blood group and antibody screen leading to serious errors in RhD immunoglobulin administration: A report on first two years of data from Serious Transfusion Incident Reporting programChristine Akers, Helen Savoia, Stefan Kane, et al.
Research and Practice in Thrombosis and Haemostasis|January 29, 2020
The clinical heterogeneity of <i>RUNX1</i> associated familial platelet disorder with predisposition to myeloid malignancy - A case series and review of the literatureCatherine Tang, David J Rabbolini, Marie-Christine Morel-Kopp, et al.
Blood Advances|July 26, 2022
Interventions to reduce infections in patients with hematological malignancies: a systematic review and meta-analysisKhai Li Chai, Jonathan Wong, Robert Weinkove, et al.
BMJ Quality Improvement Reports|August 22, 2017
Improving patient blood management in obstetrics: snapshots of a practice improvement partnershipCindy J Flores, Farah Sethna, Ben Stephens, et al.
Leukemia & Lymphoma|September 13, 2019
Outpatient rituximab, ifosfamide, etoposide (R-IE) in patients older than 60 years with relapsed or refractory diffuse large B-cell lymphoma who are not candidates for stem cell transplantationMaansi Joshi, John Taper, Cecily Forsyth, et al.
Pharmacology Research & Perspectives|October 19, 2019
<i>GSTZ1</i> genotypes correlate with dichloroacetate pharmacokinetics and chronic side effects in multiple myeloma patients in a pilot phase 2 clinical trialDan Dan Tian, Samuel K Bennett, Lucy A Coupland, et al.
Blood Advances|April 9, 2024
Immunoglobulin replacement vs prophylactic antibiotics for hypogammaglobulinemia secondary to hematological malignancyZoe K McQuilten, Robert Weinkove, Le Thi Phuong Thao, et al.
Pageof 4